Bassem El-Nabbout
Neurology with Special Qualifications in Child Neurology · Wichita, KSNPI 1558442210
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.2% of the total across 645 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 46 manufacturers, the largest accounting for just 20.0% — the pattern of someone who eats at a lot of different presentations.
Across 645 payments — averaging $18.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$2K
- Supernus Pharmaceuticals, Inc.$1K
- Jazz Pharmaceuticals Inc.$1K
- AbbVie$1K
- Neurelis, Inc.$801
- Eisai Inc.$429
- plus $4K from 40 others
Across 273 payments — averaging $1120.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Teva Pharmaceuticals USA, Inc.$259K
- Eli Lilly$38K
- Eisai Inc.$9K
What the payments were for
- Food & beverage$11,44397%
- Education$3243%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few neurology with special qualifications in child neurology providers in Kansasto place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clonazepam | 24 | $85 |
Paid to pharmacies, not to this prescriber.
Other neurology with special qualifications in child neurology in Wichita
- Subhash ShahWichita$2K
- Aruna Deepthi Markonda PatnaikWichita$1K
- Britton ZuccarelliSalina$314K
- Yu Tze NgOverland Park$92K
- Jean-Baptiste le PichonTopeka$10K
- Gina JonesTopeka$40
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.